Science

Aug 4, 2025, 06:09

Daniel Morgenstern: Mucin 16–Directed Therapy in Pediatric Sarcomas

Daniel Morgenstern, Associate Professor at University of Toronto, shared a post on LinkedIn about recent paper he and colleagues co-authored, published in Journal of Clinical Oncology.

“Another demonstration of the utility of single patient studies. Many thanks C17 Council and many others for helping make this happen”

Title: Mucin 16–Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes

Authors: Denise M. Connolly, Gabriel Revon-Rivière, Rose Chami, Denise Mills, Ailish C. Coblentz, Thomas S. Uldrick, David A. Knorr, Priscila Goncalves, Michael Dobosz, Sumreen Jalal, Sarah Cohen-Gogo, and Daniel A. Morgenstern

Read The Full Article at Journal of Clinical Oncology.

Daniel Morgenstern: Mucin 16–Directed Therapy in Pediatric Sarcomas

More posts featuring Sarcoma.

Ailish C. Coblentz C17 Council cancer Daniel Morgenstern David A. Knorr Denise M. Connolly Denise Mills Gabriel Revon-Riviere Michael Dobosz Mucin 16–Directed Therapy OncoDaily Oncology Priscila Goncalves Rose Chami Sarah Cohen-Gogo sarcoma Sumreen Jalal Thomas S. Uldrick

Hagop Kantarjian: Advances and Revolution in Adult ALL Therapy Over the Last Decade

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know

Pat Soon-Shiong: SARS-CoV-2 Infection Can Awaken Sleeping Cancer Cells